- Biotechnology
- Wednesday, 24 Jun 2020
Philogen Received Combination Pack Approval for Nidlegy
Philogen S.p.A., a privately-owned biotechnology company, is pleased to announce that, on Jan. 30, 2020, EMA's CHMP expressed a favorable opinion to the request of a combination pack for the to-be-marketed pharmaceutical form of NidlegyTM, a combination of the active principles bifikafusp alfa (L19IL2) and onfekafusp alfa (L19TNF). NidlegyTM is being developed as a neoadjuvant intralesional treatment for resectable Stage III melanoma patients and in locally advanced, not metastatic nonmelanoma skin cancers. NidlegyTM combination pack has now received confirmation of eligibility to the centralized procedure for submission of an application for a Union Marketing Authorisation under Article 3(1) - Indent 1 - Biotech medicinal product of Regulation (EC) No 726/2004.
"We are extremely pleased to record EMA's agreement to our strategy for the marketing of NidlegyTM as a combination pack that was considered by CHMP 'indispensable for public health reasons,'" commented Prof. Dario Neri, co-founder and President of the Scientific Advisory Board of Philogen.
Related Industry Updates
Bioabsorbable Implants Market Thriving Revenue by 2027 and Demand with Wright Medical Group, KLS Martin, BIOTRONIK Ltd, Syntellix AG, Q3 Medical Devices Limited., JW Medical Systems LTD
Apr 05, 2021
Intracardiac Echocardiography Market Size and Trends Study Released by Top Publisher at : Abbott oston Scientific Corporation, Koninklijke Philips N.V
Apr 06, 2021
Middle East and Africa Organoids market is expected to Rise US$ 141.26 million in 2027
Mar 15, 2021
Gel Documentation Systems Market Size 2021 Industry Analysis, Key Players, Growth Prospects, Revenue, Production, New Development, Business Share, Global Trends and Forecast To 2027
Mar 12, 2021
Middle East and Africa Organoids market is expected to Rise US$ 141.26 million in 2027
Mar 15, 2021
Immunoassay Market Shoots of US$ 37,987.8 Mn by 2027 in World with BD, Danaher Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Thermo Fisher Scientific Inc, Quidel Corporation
Apr 01, 2021
Care Management Solutions Market to Receive Overwhelming Hike in Revenues by 2027
Dec 24, 2020
Follow us on
